Sartorius Aktiengesellschaft (SUVPF)
USD 224.0
(0.0%)
USD 224.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.93 Billion EUR | 107.64% |
| 2022 | 2.37 Billion EUR | 37.09% |
| 2021 | 1.73 Billion EUR | -8.01% |
| 2020 | 1.88 Billion EUR | 86.26% |
| 2019 | 1.01 Billion EUR | 5.4% |
| 2018 | 959.46 Million EUR | 7.14% |
| 2017 | 895.54 Million EUR | 84.3% |
| 2016 | 485.9 Million EUR | 41.26% |
| 2015 | 343.99 Million EUR | -2.14% |
| 2014 | 351.51 Million EUR | 1.85% |
| 2013 | 345.14 Million EUR | 13.62% |
| 2012 | 303.77 Million EUR | 14.72% |
| 2011 | 264.8 Million EUR | 34.47% |
| 2010 | 196.92 Million EUR | -12.36% |
| 2009 | 224.7 Million EUR | 3.28% |
| 2008 | 217.56 Million EUR | 14.74% |
| 2007 | 189.62 Million EUR | 248.65% |
| 2006 | 54.38 Million EUR | -10.43% |
| 2005 | 60.72 Million EUR | -23.01% |
| 2004 | 78.87 Million EUR | 980.27% |
| 2003 | -8.96 Million EUR | 35.92% |
| 2002 | -13.98 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 4.09 Billion EUR | -16.94% |
| 2024 Q3 | 3.77 Billion EUR | -2.15% |
| 2024 Q2 | 4.03 Billion EUR | -1.57% |
| 2023 Q2 | 2.61 Billion EUR | 6.48% |
| 2023 Q4 | 4.93 Billion EUR | -2.72% |
| 2023 Q3 | 5.07 Billion EUR | 94.16% |
| 2023 FY | 4.93 Billion EUR | 107.64% |
| 2023 Q1 | 2.45 Billion EUR | 3.24% |
| 2022 Q3 | 2.34 Billion EUR | 24.66% |
| 2022 Q2 | 1.87 Billion EUR | 3.76% |
| 2022 Q4 | 2.37 Billion EUR | 1.42% |
| 2022 Q1 | 1.81 Billion EUR | 4.51% |
| 2022 FY | 2.37 Billion EUR | 37.09% |
| 2021 Q3 | 1.77 Billion EUR | 4.32% |
| 2021 FY | 1.73 Billion EUR | -8.01% |
| 2021 Q2 | 1.69 Billion EUR | -6.81% |
| 2021 Q1 | 1.82 Billion EUR | -3.24% |
| 2021 Q4 | 1.73 Billion EUR | -2.2% |
| 2020 Q3 | 1.61 Billion EUR | -3.54% |
| 2020 FY | 1.88 Billion EUR | 86.26% |
| 2020 Q1 | 951.8 Million EUR | -5.88% |
| 2020 Q2 | 1.66 Billion EUR | 75.4% |
| 2020 Q4 | 1.88 Billion EUR | 16.97% |
| 2019 FY | 1.01 Billion EUR | 5.4% |
| 2019 Q4 | 1.01 Billion EUR | -0.44% |
| 2019 Q3 | 1.01 Billion EUR | -2.01% |
| 2019 Q2 | 1.03 Billion EUR | 6.88% |
| 2019 Q1 | 969.9 Million EUR | 1.09% |
| 2018 Q4 | 959.46 Million EUR | 2.03% |
| 2018 Q2 | 955.2 Million EUR | 6.07% |
| 2018 FY | 959.46 Million EUR | 7.14% |
| 2018 Q1 | 900.5 Million EUR | 0.55% |
| 2018 Q3 | 940.4 Million EUR | -1.55% |
| 2017 FY | 895.54 Million EUR | 84.3% |
| 2017 Q1 | 796.4 Million EUR | 63.9% |
| 2017 Q3 | 911.5 Million EUR | -0.9% |
| 2017 Q4 | 895.54 Million EUR | -1.75% |
| 2017 Q2 | 919.8 Million EUR | 15.49% |
| 2016 Q3 | 498.7 Million EUR | 3.04% |
| 2016 FY | 485.9 Million EUR | 41.26% |
| 2016 Q4 | 485.9 Million EUR | -2.56% |
| 2016 Q2 | 484 Million EUR | 35.61% |
| 2016 Q1 | 356.9 Million EUR | 3.75% |
| 2015 Q4 | 343.99 Million EUR | 6.14% |
| 2015 FY | 343.99 Million EUR | -2.14% |
| 2015 Q1 | 269.7 Million EUR | -23.28% |
| 2015 Q2 | 304.4 Million EUR | 12.87% |
| 2015 Q3 | 324.1 Million EUR | 6.47% |
| 2014 FY | 351.51 Million EUR | 1.85% |
| 2014 Q3 | 367.6 Million EUR | -1.97% |
| 2014 Q1 | 347.1 Million EUR | 0.57% |
| 2014 Q4 | 351.51 Million EUR | -4.38% |
| 2014 Q2 | 375 Million EUR | 8.04% |
| 2013 Q2 | 343.1 Million EUR | 7.99% |
| 2013 Q1 | 317.7 Million EUR | 4.58% |
| 2013 FY | 345.14 Million EUR | 13.62% |
| 2013 Q4 | 345.14 Million EUR | 6.3% |
| 2013 Q3 | 324.7 Million EUR | -5.36% |
| 2012 Q4 | 303.77 Million EUR | -4.23% |
| 2012 Q3 | 317.2 Million EUR | -4.05% |
| 2012 FY | 303.77 Million EUR | 14.72% |
| 2012 Q1 | 259.8 Million EUR | -1.89% |
| 2012 Q2 | 330.6 Million EUR | 27.25% |
| 2011 Q4 | 264.8 Million EUR | -6.3% |
| 2011 FY | 264.8 Million EUR | 34.47% |
| 2011 Q2 | 217.1 Million EUR | 6.63% |
| 2011 Q3 | 282.6 Million EUR | 30.17% |
| 2011 Q1 | 203.6 Million EUR | 3.39% |
| 2010 Q4 | 196.92 Million EUR | -12.98% |
| 2010 Q1 | 233.9 Million EUR | 4.09% |
| 2010 FY | 196.92 Million EUR | -12.36% |
| 2010 Q3 | 226.3 Million EUR | -8.31% |
| 2010 Q2 | 246.8 Million EUR | 5.52% |
| 2009 Q4 | 224.7 Million EUR | 0.0% |
| 2009 FY | 224.7 Million EUR | 3.28% |
| 2008 FY | 217.56 Million EUR | 14.74% |
| 2007 FY | 189.62 Million EUR | 248.65% |
| 2006 FY | 54.38 Million EUR | -10.43% |
| 2005 FY | 60.72 Million EUR | -23.01% |
| 2004 FY | 78.87 Million EUR | 980.27% |
| 2003 FY | -8.96 Million EUR | 35.92% |
| 2002 FY | -13.98 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -1028211.348% |
| Ansell Limited | -54.99 Million USD | 9067.965% |
| Ansell Limited | -55.1 Million USD | 9051.18% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 13615.133% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 4692779.492% |
| Psykey, Inc. | 634.59 Thousand USD | -777106.808% |
| ConvaTec Group Plc | 1.2 Billion USD | -310.802% |
| ConvaTec Group Plc | 1.2 Billion USD | -310.222% |
| Encision Inc. | 1.29 Million USD | -382028.051% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -213529.475% |
| Innovative MedTech Inc. | 1.76 Million USD | -279380.897% |
| LifePoint, Inc. | -3.26 Million USD | 151205.033% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -100469.269% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -228026.735% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 11389579.032% |
| Reflect Scientific, Inc. | -1.03 Million USD | 476490.095% |
| SmileDirectClub, Inc. | 778.67 Million USD | -533.395% |
| Sector 10, Inc. | 163 Thousand USD | -3025728.221% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 1281.188% |
| SheerVision, Inc. | 57.34 Thousand USD | -8600049.959% |
| United Health Products, Inc. | 660.56 Thousand USD | -746544.181% |
| Vasamed, Inc. | 22.12 Thousand USD | -22294900.452% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -187345.439% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -638542.252% |